The use of 18F-FDG PET/CT to guide management of adrenal histoplasmosis over time

The use of ¹⁸F-FDG PET/CT to guide management of adrenal histoplasmosis over time

Eur J Nucl Med Mol Imaging. 2021 Apr;48(4):1250-1251. doi: 10.1007/s00259-020-05016-1. Epub 2020 Aug 31.

S Parisien-La Salle¹, P Morency-Potvin², M Lord³, F Mercier⁴, B P Dubé⁵, C Cohade^{3

6}, I Bourdeau⁷

¹ Division of Endocrinology, Department of Medicine, Research Center, Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Canada.
² Division of Infectious Diseases, Department of Medicine, Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Canada.
³ Department of Radiology, Radio-oncology and Nuclear Medicine, Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Canada.
⁴ Surgical Oncology Service, Department of Surgery, Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Canada.
⁵ Division of Respirology, Department of Medicine, Research Center, Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Canada.
⁶ Department of Radiology and Nuclear Medicine, Hôpital Maisonneuve-Rosemont, Montreal, Canada.
⁷ Division of Endocrinology, Department of Medicine, Research Center, Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Canada. isabelle.bourdeau@umontreal.ca.

No abstract available